These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9394341

  • 21. Tacrolimus as the first-line agent in adult-onset minimal change disease: A randomized controlled study.
    Patil MR, Divyaveer SS, Raychaudhary A, Trivedi M, Mahajan C, Sarkar D, Pandey R.
    Saudi J Kidney Dis Transpl; 2019; 30(1):129-137. PubMed ID: 30804274
    [Abstract] [Full Text] [Related]

  • 22. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida M.
    Clin Pharmacol Ther; 2000 Nov; 68(5):532-40. PubMed ID: 11103756
    [Abstract] [Full Text] [Related]

  • 23. Minimal change disease and Kimura's disease responding to tacrolimus therapy.
    Balwani MR, Bawankule CP, Pasari A, Tolani P, Vakil S, Yadav R.
    Saudi J Kidney Dis Transpl; 2019 Nov; 30(1):254-257. PubMed ID: 30804291
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy.
    Kano K, Nishikura K, Hoshi M, Yamada Y, Arisaka O.
    Clin Nephrol; 2001 May; 55(5):424-5. PubMed ID: 11393392
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
    Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H.
    Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
    [Abstract] [Full Text] [Related]

  • 26. Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-Resistant Nephrotic Syndrome.
    Shah SS, Hafeez F.
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):589-93. PubMed ID: 27504551
    [Abstract] [Full Text] [Related]

  • 27. A new approach to de novo minimal change disease in pregnancy.
    Gleeson S, Cardoso F, Lightstone L, Webster P, Munro K, Cairns T.
    Nephrology (Carlton); 2021 Aug; 26(8):692-693. PubMed ID: 33728704
    [No Abstract] [Full Text] [Related]

  • 28. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

  • 29. Effective improvement of minimal change nephrotic syndrome with uncontrollable high low-density lipoprotein cholesterol level using evolocumab accompanied by the development of acute pancreatitis.
    Asai R, Kaneko T, Seki M, Tsuruoka S.
    CEN Case Rep; 2020 Nov; 9(4):333-337. PubMed ID: 32358739
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 31. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M.
    Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
    [Abstract] [Full Text] [Related]

  • 32. Use of cyclosporin A for successful management of steroid-resistant Sweet's syndrome patient with possible myelodysplastic syndrome.
    Yasuda F, Fujio Y, Kakuta R, Funakoshi T, Amagai M, Ohyama M.
    J Dermatol; 2014 May; 41(5):465-6. PubMed ID: 24750407
    [No Abstract] [Full Text] [Related]

  • 33. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, van den Wall Bake AWL, Rensma PL, Konings CJ, Geerse DA, Feith GW, Van Kuijk WH, Wetzels JF.
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [Abstract] [Full Text] [Related]

  • 34. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A, Sabry S, Emil E, El-Refaey M.
    J Nephrol; 2012 May; 25(5):732-7. PubMed ID: 22101675
    [Abstract] [Full Text] [Related]

  • 35. [Cyclosporin A treatment of adult patients with severe nephrotic syndrome].
    Nyrop M, Olgaard K.
    Ugeskr Laeger; 1992 Jul 06; 154(28):1944-8. PubMed ID: 1509556
    [Abstract] [Full Text] [Related]

  • 36. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
    Wyszyńska T, Ksiazek J, Wieteska-Klimczak A, Gorzkowska-Paczwa M, Dorywalski T, Tysarowska A.
    Pol Merkur Lekarski; 2001 Aug 06; 11(62):140-3. PubMed ID: 11757213
    [Abstract] [Full Text] [Related]

  • 37. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ, Wetzels JF.
    Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257
    [Abstract] [Full Text] [Related]

  • 38. [Treatment-resistant adult atopic dermatitis].
    Esteve-Martínez A, García-Rabasco A, Miralles J, de-la-Cuadra-Oyanguren J.
    Actas Dermosifiliogr; 2011 Dec 26; 102(10):821-2. PubMed ID: 21820642
    [No Abstract] [Full Text] [Related]

  • 39. [Nephrotic syndrome in childhood].
    Reusz G, Szabó A, Fekete A.
    Orv Hetil; 2006 Nov 26; 147(47):2251-60. PubMed ID: 17380687
    [Abstract] [Full Text] [Related]

  • 40. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T, Nast CC, Vo A, Jordan SC.
    Nephrol Dial Transplant; 2008 Jan 26; 23(1):377-80. PubMed ID: 17981884
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.